|
Market Closed -
OTC Markets
18:42:53 15/07/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -99.00% |
| Market Cap | 6.24M 4.52M 3.88M 3.65M 3.34M 427M 6.26M 43.32M 16.75M 219M 16.96M 16.59M 697M | P/E 2022 |
-2.09x | P/E 2023 | -0.45x |
|---|---|---|---|---|---|
| Enterprise Value | 64.5M 46.71M 40.17M 37.78M 34.49M 4.42B 64.71M 448M 173M 2.26B 175M 172M 7.21B | EV / Sales 2022 |
3.37x | EV / Sales 2023 | 1.35x |
| Free-Float |
52.66% | Yield 2022 * |
-
| Yield 2023 | - |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 0.84 |
| 10 years | 0 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Tougas
DFI | Director of Finance/CFO | - | 20/11/2023 |
Nelly Komari
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2021 |
Frédéric Dumais
IRC | Investor Relations Contact | - | 01/06/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven Saviuk
CHM | Chairman | 67 | 06/08/2024 |
Richard MacKay
CHM | Chairman | 91 | 25/07/2018 |
Marc Léger
BRD | Director/Board Member | 67 | 27/04/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/11/24 | Other | Investor Relations Manager | 0 | 0% | ||
| 11/11/24 | Other | Investor Relations Manager | 0 | 0% | ||
| 11/11/24 | Other | Investor Relations Manager | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 98 | |
| -0.88% | -0.64% | +58.05% | +100.51% | 1,024B | |
| -1.15% | +3.53% | +54.25% | +71.99% | 663B | |
| -1.44% | +0.02% | +20.65% | +72.22% | 453B | |
| -0.48% | +1.58% | +30.69% | +37.51% | 349B | |
| -9.47% | -12.81% | +11.59% | +29.57% | 295B | |
| -0.90% | -0.05% | -0.12% | +10.23% | 253B | |
| -1.55% | +1.71% | +54.15% | +71.87% | 236B | |
| -0.97% | +0.78% | -14.63% | -56.29% | 206B | |
| -0.15% | +3.18% | +31.24% | +104.21% | 187B | |
| Average | -1.89% | +1.05% | +27.32% | +49.09% | 366.73B | |
| Weighted average by Cap. | -1.64% | +0.52% | +36.69% | +63.47% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 27.74M 20.09M 17.28M 16.25M 14.83M 1.9B 27.83M 193M 74.48M 973M 75.45M 73.8M 3.1B | 53.91M 39.04M 33.57M 31.58M 28.83M 3.69B 54.08M 374M 145M 1.89B 147M 143M 6.02B |
| Net income | -25.75M -18.64M -16.03M -15.08M -13.77M -1.76B -25.83M -179M -69.12M -903M -70.02M -68.48M -2.88B | -27.81M -20.14M -17.32M -16.29M -14.87M -1.9B -27.9M -193M -74.65M -975M -75.62M -73.97M -3.11B |
| Net Debt | 38.94M 28.2M 24.25M 22.81M 20.82M 2.67B 39.07M 270M 105M 1.37B 106M 104M 4.35B | 58.26M 42.19M 36.28M 34.12M 31.15M 3.99B 58.45M 405M 156M 2.04B 158M 155M 6.51B |
Employees
70
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VPHIF Stock
Select your edition
All financial news and data tailored to specific country editions
